These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


23 related items for PubMed ID: 12660508

  • 1. Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion.
    Schütte H, Schell A, Schäfer C, Ghofrani A, Theo Schermuly R, Seeger W, Grimminger F.
    Transplantation; 2003 Mar 27; 75(6):814-21. PubMed ID: 12660508
    [Abstract] [Full Text] [Related]

  • 2. Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion.
    Schütte H, Schell A, Schäfer C, Ghofrani A, Theo Schermuly R, Seeger W, Grimminger F.
    Transplantation; 2003 Mar 27; 75(6):814-21. PubMed ID: 12660508
    [Abstract] [Full Text] [Related]

  • 3. Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.
    Schermuly RT, Roehl A, Weissmann N, Ghofrani HA, Schudt C, Tenor H, Grimminger F, Seeger W, Walmrath D.
    J Pharmacol Exp Ther; 2000 Feb 27; 292(2):512-20. PubMed ID: 10640287
    [Abstract] [Full Text] [Related]

  • 4. Nebulized phosphodiesterase III inhibitor during warm ischemia attenuates pulmonary ischemia-reperfusion injury.
    Zhang J, Chen F, Zhao X, Aoyama A, Okamoto T, Fujinaga T, Shoji T, Sakai H, Cui Y, Bando T, Date H.
    J Heart Lung Transplant; 2009 Jan 27; 28(1):79-84. PubMed ID: 19134535
    [Abstract] [Full Text] [Related]

  • 5. Reduced ischemia-reperfusion injury with rolipram in rat cadaver lung donors: effect of cyclic adenosine monophosphate.
    Bleiweis MS, Jones DR, Hoffmann SC, Becker RM, Egan TM.
    Ann Thorac Surg; 1999 Jan 27; 67(1):194-9; discussion 199-200. PubMed ID: 10086548
    [Abstract] [Full Text] [Related]

  • 6. Pulmonary edema: ischemia reperfusion endothelial injury and its reversal by c-AMP.
    Taylor AE.
    Proc Natl Sci Counc Repub China B; 1991 Jul 27; 15(3):191-5. PubMed ID: 1668019
    [Abstract] [Full Text] [Related]

  • 7. Adenosine triphosphate-magnesium chloride: relevance for intensive care.
    Nalos M, Asfar P, Ichai C, Radermacher P, Leverve XM, Fröba G.
    Intensive Care Med; 2003 Jan 27; 29(1):10-8. PubMed ID: 12528016
    [Abstract] [Full Text] [Related]

  • 8. Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion.
    Schütte H, Schell A, Schäfer C, Ghofrani A, Theo Schermuly R, Seeger W, Grimminger F.
    Transplantation; 2003 Mar 27; 75(6):814-21. PubMed ID: 12660508
    [Abstract] [Full Text] [Related]

  • 9. Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.
    Schermuly RT, Roehl A, Weissmann N, Ghofrani HA, Schudt C, Tenor H, Grimminger F, Seeger W, Walmrath D.
    J Pharmacol Exp Ther; 2000 Feb 27; 292(2):512-20. PubMed ID: 10640287
    [Abstract] [Full Text] [Related]

  • 10. Nebulized phosphodiesterase III inhibitor during warm ischemia attenuates pulmonary ischemia-reperfusion injury.
    Zhang J, Chen F, Zhao X, Aoyama A, Okamoto T, Fujinaga T, Shoji T, Sakai H, Cui Y, Bando T, Date H.
    J Heart Lung Transplant; 2009 Jan 27; 28(1):79-84. PubMed ID: 19134535
    [Abstract] [Full Text] [Related]

  • 11. Reduced ischemia-reperfusion injury with rolipram in rat cadaver lung donors: effect of cyclic adenosine monophosphate.
    Bleiweis MS, Jones DR, Hoffmann SC, Becker RM, Egan TM.
    Ann Thorac Surg; 1999 Jan 27; 67(1):194-9; discussion 199-200. PubMed ID: 10086548
    [Abstract] [Full Text] [Related]

  • 12. Microvascular in vivo assessment of reperfusion injury: significance of prostaglandin E(1) and I(2) in postischemic "no-reflow" and "reflow-paradox".
    Tauber S, Menger MD, Lehr HA.
    J Surg Res; 2004 Jul 27; 120(1):1-11. PubMed ID: 15172184
    [Abstract] [Full Text] [Related]

  • 13. Rolipram and isoproterenol reverse platelet activating factor-induced increases in pulmonary microvascular permeability and vascular resistance.
    Noel PE, Fletcher JR, Thompson WJ.
    J Surg Res; 1995 Jul 27; 59(1):159-64. PubMed ID: 7630121
    [Abstract] [Full Text] [Related]

  • 14. Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion.
    Schütte H, Schell A, Schäfer C, Ghofrani A, Theo Schermuly R, Seeger W, Grimminger F.
    Transplantation; 2003 Mar 27; 75(6):814-21. PubMed ID: 12660508
    [Abstract] [Full Text] [Related]

  • 15. Pulmonary edema: ischemia reperfusion endothelial injury and its reversal by c-AMP.
    Taylor AE.
    Proc Natl Sci Counc Repub China B; 1991 Jul 27; 15(3):191-5. PubMed ID: 1668019
    [Abstract] [Full Text] [Related]

  • 16. Adenosine triphosphate-magnesium chloride: relevance for intensive care.
    Nalos M, Asfar P, Ichai C, Radermacher P, Leverve XM, Fröba G.
    Intensive Care Med; 2003 Jan 27; 29(1):10-8. PubMed ID: 12528016
    [Abstract] [Full Text] [Related]

  • 17. Microvascular Leakage as Therapeutic Target for Ischemia and Reperfusion Injury.
    Kloka JA, Friedrichson B, Wülfroth P, Henning R, Zacharowski K.
    Cells; 2023 May 09; 12(10):. PubMed ID: 37408180
    [Abstract] [Full Text] [Related]

  • 18. Prostacyclin in sepsis: a systematic review.
    Zardi EM, Zardi DM, Dobrina A, Afeltra A.
    Prostaglandins Other Lipid Mediat; 2007 Feb 09; 83(1-2):1-24. PubMed ID: 17259068
    [Abstract] [Full Text] [Related]

  • 19. Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion.
    Schütte H, Schell A, Schäfer C, Ghofrani A, Theo Schermuly R, Seeger W, Grimminger F.
    Transplantation; 2003 Mar 27; 75(6):814-21. PubMed ID: 12660508
    [Abstract] [Full Text] [Related]

  • 20. Pulmonary edema: ischemia reperfusion endothelial injury and its reversal by c-AMP.
    Taylor AE.
    Proc Natl Sci Counc Repub China B; 1991 Jul 27; 15(3):191-5. PubMed ID: 1668019
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 2.